Back to Search Start Over

Authors’ reply to the letter to the editor regarding 'Effect of empagliflozin on plasma proprotein convertase subtilisin/kexin type 9 (PCSK9) in patients with type 2 diabetes'

Authors :
Domenico Tricò
Anna Solini
Source :
Diabetes Research and Clinical Practice. 191:110018
Publication Year :
2022
Publisher :
Elsevier BV, 2022.

Details

ISSN :
01688227
Volume :
191
Database :
OpenAIRE
Journal :
Diabetes Research and Clinical Practice
Accession number :
edsair.doi.dedup.....de8f5ca12beff38e670261a9c99cb03c
Full Text :
https://doi.org/10.1016/j.diabres.2022.110018